Is CRISPR Therapeutics (CRSP) Attractive After Recent Gene Editing Progress And Mixed Returns? [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
The stock has seen a mixed return profile, with a 0.1% move over the past week, a 6.5% decline over 30 days, a flat 0.1% year to date, a 35.7% return over 1 year, 7.8% over 3 years and a 73.1% decline over 5 years, which gives very different signals depending on your time frame. Recent headlines around CRISPR Therapeutics have focused on its gene editing platform and its progress in bringing therapies closer to patients, which has kept interest in the stock alive. At the same time, regulatory developments, partnership updates and sentiment around high risk biotech names have all fed into the share price moves you are seeing. On our checks the company scores 4 out of 6 on valuation. You can see the full breakdown of that valuation score . This sets us up to compare different methods of assessing value next, then finish by looking at an even richer way to think about what the stock might be worth beyond the numbers alone. CRISPR Therapeutics delivered 35.7% returns over the last
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 MilestonesGlobeNewswire
- CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 11/10/25 - Beat
CRSP
Sec Filings
- 1/12/26 - Form 8-K
- 1/8/26 - Form 4
- 1/6/26 - Form 144
- CRSP's page on the SEC website